Clinical Trial Update: Non-inferiority Evaluation of Trimbow in Critically Ill Patients Admitted in ICU Compared to Standard of Care [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating non-inferiority of Trimbow versus standard of care in critically ill COPD_exacerbation patients admitted to ICU.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• Trimbow (budesonide/formoterol/glycopyrronium)

Snippet

Sponsor: PARZIBUT Gilles | Conditions: COPD Exacerbation | Phase 4 | Status: UNKNOWN